Managing your child's nearsightedness is not a single appointment or a one-time treatment. It is a structured process that unfolds over months and years, with specific milestones along the way. Understanding the timeline helps you plan for follow-up visits, set realistic expectations for results, and stay engaged as an active participant in your child's eye care. Most children begin treatment between ages six and twelve and continue until their eyes stop growing, typically in their late teens or early twenties.
According to a peer-reviewed study published in 2018, myopia progresses fastest in children ages seven to ten. Starting treatment during this critical window gives your eye doctor the best opportunity to slow progression when it is most active. Waiting until the teenage years means missing the period when the eyes are growing most rapidly and when treatment can have the greatest cumulative impact.
According to a peer-reviewed analysis, half of myopic children reach a stable prescription by age sixteen, while the other half continue progressing into their twenties. This variability means your eye doctor cannot predict exactly when your child's eyes will stop changing. Instead, the treatment plan is guided by ongoing measurements that track the actual rate of change at each visit, allowing adjustments as the pattern becomes clearer over time.
The first visit is the most thorough. At Insight Vision Optometry, Las Vegas, your child receives a comprehensive eye exam that includes a detailed refraction to measure the current prescription, corneal topography mapping, and axial length measurement. Axial length, the distance from the front to the back of the eye, is the most precise indicator of myopia progression. This measurement becomes the baseline against which all future progress is compared.
Your eye doctor also evaluates the factors that influence how quickly your child's myopia is likely to progress. These include the age at which myopia first appeared, the current rate of change if prior records are available, family history of nearsightedness, how much time the child spends on near work versus outdoor activity, and the child's overall eye health. This risk assessment helps determine how aggressively treatment should begin.
Based on the evaluation, your eye doctor presents the treatment options that are most appropriate for your child's age, prescription, risk profile, and family preferences. Options may include orthokeratology lenses, low-dose atropine drops, myopia control spectacle lenses, or multifocal soft contact lenses. Once you and your eye doctor agree on an approach, treatment begins immediately. If contact lenses are chosen, the fitting and training process takes place during this visit or a separate fitting appointment.
The first few weeks after starting treatment involve building a consistent daily routine. If your child is using ortho-K lenses, this means nightly insertion and morning removal. If using atropine drops, it means one drop per eye at bedtime. If using daytime contact lenses, it means insertion each morning and removal each evening. Most children adapt to their new routine within the first one to two weeks, with parental involvement being especially helpful during this initial period.
Your child will return for a follow-up visit within the first month. At this visit, your eye doctor checks the fit of any lenses, assesses comfort and visual clarity, and confirms that the treatment is being used correctly. For ortho-K patients, the corneal response is evaluated to verify that the reshaping is occurring as expected. For atropine patients, pupil size and any light sensitivity are assessed. This early visit is an opportunity to address any concerns and fine-tune the routine before settling into longer-term monitoring.
At one month, it is too early to measure meaningful changes in myopia progression. The purpose of this visit is to confirm that the treatment is being used properly and that your child is comfortable. Vision improvements from ortho-K are typically noticeable within the first week, but the myopia-slowing effect of all treatments is measured over longer intervals. This is a marathon, not a sprint, and the value of consistent treatment compounds with each passing month.
The six-month visit is when your eye doctor collects the first meaningful data on whether the treatment is slowing your child's myopia progression. The prescription and axial length are remeasured and compared against the baseline from the first visit. If the rate of change is slower than expected for an untreated child of the same age, the treatment is working. Your eye doctor will share these numbers with you and explain what they mean in the context of your child's specific situation.
If the six-month data shows that progression is slower than expected, the current treatment continues unchanged. If progression is faster than expected, your eye doctor may consider adjusting the approach. This could mean increasing the atropine concentration, switching to a different lens type, or adding a complementary treatment. The data from this visit is what drives the decision, ensuring that adjustments are based on evidence rather than assumptions.
Six months is also a good checkpoint for reviewing the daily routine. Are the lenses being worn consistently every night? Are the drops being used at the same time each evening? Is the child getting adequate outdoor time? Small inconsistencies in the routine can accumulate over time and affect results. This visit is a chance to troubleshoot any challenges and recommit to the habits that support the best outcome.
The one-year visit provides a more robust picture of how effectively the treatment is controlling your child's myopia. With a full year of axial length measurements, your eye doctor can identify whether the rate of eye growth has slowed compared to the average untreated progression for children of the same age. One year of data is typically enough to confirm that the chosen treatment is on track or to identify a need for a change in strategy.
Your eye doctor compares your child's measured progression against published data on average untreated progression rates for children of the same age, ethnicity, and risk profile. This comparison quantifies how much slowing the treatment has achieved. Families from Henderson, Enterprise, Paradise, Spring Valley, and throughout the Las Vegas area receive a detailed review of these numbers at the one-year milestone so they understand the value the treatment is providing.
The one-year visit is also when your eye doctor discusses the longer-term plan. Treatment will continue as long as the eyes are still growing and progressing. Annual assessments will track whether the current approach remains effective or whether adjustments are needed. As your child matures, the treatment plan may evolve. A child who started with atropine drops at age seven may transition to ortho-K at age ten as their maturity and independence grow. The plan stays flexible and responsive to your child's changing needs.
After the first year, most children continue with follow-up visits every six months. Each visit includes refraction and axial length measurement, providing ongoing data points that map the trajectory of your child's myopia over time. Insight Vision Optometry, Las Vegas maintains a longitudinal record for each patient, allowing trend analysis that reveals whether the treatment effect is holding steady, strengthening, or showing signs of reduced efficacy.
As your child approaches their late teens, myopia progression typically begins to slow naturally. Your eye doctor will watch for signs that the eyes are stabilizing: minimal changes in axial length between visits, a stable prescription over consecutive measurements, and age-appropriate growth patterns. When these criteria are met, your eye doctor will discuss gradually tapering and eventually discontinuing treatment. This transition is managed carefully to avoid any rebound acceleration in progression.
Most children have visits at one month, three months, and six months after starting treatment, then every six months thereafter. Children with rapid progression or recent treatment adjustments may be seen more frequently. Each visit includes objective measurements that track progress, so the schedule is tailored to provide the data needed to manage your child's care effectively.
Missing a single follow-up is not an emergency, but it is important to reschedule as soon as possible. Regular measurements are how your eye doctor tracks whether the treatment is working. Gaps in data make it harder to identify trends or catch changes early. If you need to reschedule, contact your eye doctor's office so the next visit can be arranged promptly.
It may. As your child grows, their needs, maturity, and preferences evolve. A child who started with atropine drops at age six may transition to ortho-K at age nine. A child who began with glasses-based myopia control may switch to contact lenses as they become more independent. Your eye doctor reassesses the approach at regular intervals and makes changes when the data or circumstances support a shift.
Treatment is typically continued until multiple consecutive measurements show that myopia progression has slowed to a minimal rate, usually in the late teens or early twenties. Your eye doctor will use axial length trends and prescription stability to guide this decision. Stopping treatment is a gradual process involving tapering rather than an abrupt end, to minimize any rebound effect.
Yes. While starting earlier provides more years of potential slowing, treatment can begin at any age where myopia is still progressing. Even teenagers who were not diagnosed until recently can benefit from myopia management if their eyes are still growing. Your eye doctor will evaluate the current progression rate and recommend the most appropriate approach based on your child's age and prescription.
